CA2341308A1 - Human latent transforming growth factor-.beta. binding protein 3 - Google Patents

Human latent transforming growth factor-.beta. binding protein 3 Download PDF

Info

Publication number
CA2341308A1
CA2341308A1 CA002341308A CA2341308A CA2341308A1 CA 2341308 A1 CA2341308 A1 CA 2341308A1 CA 002341308 A CA002341308 A CA 002341308A CA 2341308 A CA2341308 A CA 2341308A CA 2341308 A1 CA2341308 A1 CA 2341308A1
Authority
CA
Canada
Prior art keywords
seq
gly
hltbp
nucleic acid
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002341308A
Other languages
English (en)
French (fr)
Inventor
Brian Taylor Edmonds
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2341308A1 publication Critical patent/CA2341308A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA002341308A 1998-09-01 1999-08-30 Human latent transforming growth factor-.beta. binding protein 3 Abandoned CA2341308A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9876698P 1998-09-01 1998-09-01
US60/098,766 1998-09-01
PCT/US1999/019436 WO2000012551A1 (en) 1998-09-01 1999-08-30 HUMAN LATENT TRANSFORMING GROWTH FACTOR-β BINDING PROTEIN 3

Publications (1)

Publication Number Publication Date
CA2341308A1 true CA2341308A1 (en) 2000-03-09

Family

ID=22270787

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002341308A Abandoned CA2341308A1 (en) 1998-09-01 1999-08-30 Human latent transforming growth factor-.beta. binding protein 3

Country Status (7)

Country Link
EP (1) EP1109829A4 (de)
JP (1) JP2002535957A (de)
AU (1) AU5900799A (de)
CA (1) CA2341308A1 (de)
HU (1) HUP0103201A2 (de)
IL (1) IL141610A0 (de)
WO (1) WO2000012551A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Also Published As

Publication number Publication date
EP1109829A1 (de) 2001-06-27
WO2000012551A1 (en) 2000-03-09
EP1109829A4 (de) 2003-01-02
HUP0103201A2 (hu) 2001-12-28
IL141610A0 (en) 2002-03-10
JP2002535957A (ja) 2002-10-29
AU5900799A (en) 2000-03-21

Similar Documents

Publication Publication Date Title
US5928939A (en) Vascular endothelial growth factor-b and dna coding therefor
JP4124815B2 (ja) TGF−β型受容体cDNAおよびその用途
US6610510B1 (en) Morphogenic proteins
JP2003521893A (ja) 線維芽細胞増殖因子様ポリペプチド
WO1999037671A1 (en) Vegf related gene and protein
CA2324476A1 (en) Treatment and prevention of vascular disease
CA2310987A1 (en) Tnf ligand family gene
CA2295439A1 (en) Mammalian neuro-growth factor like protein
EP0962530A2 (de) Gensequenz, dass für das angiopoietinverwandte Protein Scarface 1 kodiert
WO1999026976A1 (en) Tnf ligand family gene
EP0962466A1 (de) Angiopoietin verwandtes Gen, Scarface 3
WO2000059940A2 (en) Platelet-derived growth factor related gene and protein
CA2341308A1 (en) Human latent transforming growth factor-.beta. binding protein 3
WO1999033967A2 (en) Novel nucleic acid and polypeptide with homology to the tnf-receptors
EP0984063A2 (de) Vegf-verwandtes gen und protein
US20020026043A1 (en) Desert hedgehog related nucleic acids and proteins
EP0995759A1 (de) Angiopoietin-verwandte Gensequenz Scarface 2
AU753400C (en) Orphan receptors
MXPA01001929A (en) HUMAN LATENT TRANSFORMING GROWTH FACTOR-&bgr;BINDING PROTEIN 3
AU2008201780B2 (en) Fibroblast growth factor-like polypeptides
WO2001074860A2 (en) Methods of identifying integrin ligands using differential gene expression
US20030228653A1 (en) Novel orphan cytokine receptor polypeptides
WO1999023110A1 (en) Hptlg gene from human hypothalamus
WO2000041537A2 (en) Use of desert hedgehog protein
HK1144437A (en) Fibroblast growth factor-like polypeptides

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued